Spatial immunoprofiling of adenoid cystic carcinoma reveals B7-H4 is a therapeutic target for aggressive tumors
LG Sousa, DJ McGrail, F Lazar Neto, K Li… - Clinical Cancer …, 2023 - AACR
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
LG Sousa, DJ McGrail, F Lazar Neto, K Li… - Clinical Cancer …, 2023 - AACR
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
LG Sousa, DJ McGrail, FL Neto… - Clinical Cancer …, 2023 - mdanderson.elsevierpure.com
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous Results: RNA deconvolution
revealed that most ACCs are immumalignancy, and no effective systemic therapy exists for …
revealed that most ACCs are immumalignancy, and no effective systemic therapy exists for …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
LG SOUSA, DJ MCGRAIL, FL NETO… - Clinical Cancer …, 2023 - observatorio.fm.usp.br
Purpose: Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
LG Sousa, DJ McGrail, FL Neto, K Li… - … : an official journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
LG Sousa, DJ McGrail, K Li… - … Cancer Research: an …, 2023 - europepmc.org
Purpose Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
LG de Sousa, DJ McGrail, K Li… - … Cancer Research: an …, 2023 - europepmc.org
Purpose Adenoid cystic carcinoma (ACC) is a heterogeneous malignancy, and no effective
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …
systemic therapy exists for metastatic disease. We previously described two prognostic ACC …